Turn Therapeutics Inc.
TTRX
$5.19
-$0.06-1.14%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 1.30M | 839.80K | 419.50K | 419.50K | 286.20K |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.37M | 875.80K | 501.00K | 501.00K | 360.20K |
| Operating Income | -1.37M | -875.80K | -501.00K | -501.00K | -360.20K |
| Income Before Tax | -1.24M | -784.50K | -494.80K | -494.80K | -351.90K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.24M | -784.50K | -494.80K | -494.80K | -351.90K |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -1.24M | -784.50K | -494.80K | -494.80K | -351.90K |
| EBIT | -1.37M | -875.80K | -501.00K | -501.00K | -360.20K |
| EBITDA | -1.35M | -863.30K | -488.70K | -488.70K | -348.70K |
| EPS Basic | -0.05 | -0.03 | -0.02 | -0.02 | -0.01 |
| Normalized Basic EPS | -0.03 | -0.02 | -0.01 | -0.01 | -0.01 |
| EPS Diluted | -0.05 | -0.03 | -0.02 | -0.02 | -0.01 |
| Normalized Diluted EPS | -0.03 | -0.02 | -0.01 | -0.01 | -0.01 |
| Average Basic Shares Outstanding | 27.49M | 27.20M | 27.19M | 27.19M | 26.50M |
| Average Diluted Shares Outstanding | 27.49M | 27.20M | 27.19M | 27.19M | 26.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |